- Home
- MNKD vs UTL Comparison
MNKD vs UTL Comparison
Compare MNKD & UTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MNKD | UTL |
|---|---|---|
| Founded | 1991 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Power Generation |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 877.0M | 906.9M |
| IPO Year | 2004 | 1995 |
Fundamental Metrics
Financial Performance| Metric | MNKD | UTL |
|---|---|---|
| Price | $3.52 | $51.68 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 2 |
| Target Price | $8.69 | ★ $56.50 |
| AVG Volume (30 Days) | ★ 6.3M | 82.7K |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 3.65% |
| EPS Growth | N/A | ★ 1.37 |
| EPS | N/A | ★ 1.85 |
| Revenue | $348,966,000.00 | ★ $536,000,000.00 |
| Revenue This Year | $35.81 | $5.43 |
| Revenue Next Year | $11.89 | $4.22 |
| P/E Ratio | ★ N/A | $27.96 |
| Revenue Growth | ★ 22.23 | 8.33 |
| 52 Week Low | $2.23 | $45.11 |
| 52 Week High | $6.51 | $55.12 |
Technical Indicators
Market Signals| Indicator | MNKD | UTL |
|---|---|---|
| Relative Strength Index (RSI) | 64.71 | 51.80 |
| Support Level | $2.45 | $51.41 |
| Resistance Level | $6.08 | $53.65 |
| Average True Range (ATR) | 0.26 | 1.04 |
| MACD | 0.02 | 0.16 |
| Stochastic Oscillator | 43.01 | 87.94 |
Price Performance
Historical ComparisonAbout MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.
About UTL UNITIL Corporation
Unitil Corp through its subsidiaries engages in the distribution of electricity and natural gas in its service territories in the states of New Hampshire, Massachusetts and Maine. Its natural gas operations include gas distribution utility operations and interstate gas transmission pipeline operations. It also engages in interstate natural gas transmission pipeline company, operating approximately 85 miles of underground gas transmission pipeline located in Maine and New Hampshire. The company's segments include Electric and Gas.